A review on endocrine disruptors and their possible impacts on human health

Environmental Toxicology and Pharmacology

Volumn 40, Issue 1, 2015, Pages 241-258

  Kabir, Eva Rahman ^a   Rahman, Monica Sharfin ^a   Rahman, Imon ^a  

^a BRAC UNIVERSITY   (Bangladesh)

Author keywords

Chemicals; Endocrine disruption; Hormones; Organs; Toxicity

Indexed keywords

CHEMICAL COMPOUND; ENDOCRINE DISRUPTOR; WATER;

AIR; COMMUNITY; DIET; ENDOCRINE FUNCTION; ENVIRONMENTAL EXPOSURE; HEALTH STATUS; HUMAN; NONHUMAN; OCCUPATIONAL EXPOSURE; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOIL; VULNERABLE POPULATION; WILDLIFE; AWARENESS;

AWARENESS; ENDOCRINE DISRUPTORS; HUMANS;

EID: 84936870588     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2015.06.009     Document Type: Review

References (61)

1. National Institute of Environmental Health Sciences 2010.
2. Agrell C., et al. Evidence of latitudinal fractionation of polychlorinated biphenyl congeners along the Baltic Sea region. Environ. Sci. Technol. 1999, 33(8):1149-1156. 10.1021/es980867l.
3. Andersen H.R., et al. Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol. Appl. Pharmacol. 2002, 179(1):1-12. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11884232.
4. ATSDR Toxicological Profile for 1,2-Dichloroethane 2001, U.S. Department of Health and Human Services, Public Health Service, Available at: http://www.atsdr.cdc.gov/toxprofiles/tp38.pdf.
5. Bay K., et al. Testicular dysgenesis syndrome: possible role of endocrine disruptors. Best Pract. Res. Clin. Endocrinol. Metab. 2006, 20(1):77-90.
6. Belfroid A.C., et al. Analysis and occurrence of estrogenic hormones and their glucuronides in surface water and waste water in The Netherlands. Sci. Total Environ. 1999, 225:101-108.
7. Blumberg B. Endocrine disruptors as obesogens. Mol. Cell. Endocrinol. 2009, 304:19-29.
8. Caliman F.A., Gavrilescu M. Pharmaceuticals, personal care products and endocrine disrupting agents in the environment - a review. Clean - Soil Air Water 2009, 37(4-5):277-303.
9. Casals-Casas C., Feige J.N., Desvergne B. Interference of pollutants with PPARs: endocrine disruption meets metabolism. Int. J. Obes. 2008, 53-61. 10.1038/ijo.2008.207.
10. Center for Disease Control and Prevention 2014, http://www.cdc.gov/nchs/data/hus/hus 13.pdf.
11. Colborn T., Clement C. Chemically-induced Alterations in Sexual and Functional Development: The Wildlife/human Connection 1992, Princeton Scientific Pub. Co., Princeton, NJ.
12. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 1993, 101(5):378-384.
13. Comhaire F.H., Mahmoud A.M., Schoonjans F. Sperm quality, birth rates and the environment in Flanders (Belgium). Reprod. Toxicol. 2007, 23(2):133-137.
14. Costa E.M.F., Spritzer P.M., Hohl A., Bachega T.A.S.S. Effects of endocrine disruptors in the development of the female reproductive tract. Arq. Bras. Endocrinol. Metab. 2014, 58(2):153-161. doi:10.1590.0004-2730000003031.
15. Cristina P., Maria C.U., Carmen V. Endocrine disruptors in the environment and their impact on human health. Environ. Eng. Manage. J. 2012, 11(9):1697-1706.
16. Curado P., Edwards B., Shin H.R., et al. Cancer Incidence in Five Continents 2007, vol. 9. IARC Scientific Publication, Lyon, France, Available at: http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/CI5vol9-A.pdf.
17. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 1999, 107(6):907-938.
18. Den H.E., Roels H.A., Hoppenbrouwers K., Nawrot T., Thijs L., Vandermeulen C., Winneke G., Vanderschueren D., Staessen J.A. Sexual maturation in relation to polychlorinated aromatic hydrocarbons: Sharpe and Skakkebaek's hypothesis revisited. Environ. Health Perspect. 2002, 110:771-776.
19. Desbrow C., Routledge E.J., Brighty G.C., Sumpter J.P., Waldock M. Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environ. Sci. Technol. 1998, 32(11):1549-1558. 10.1021/es9707973.
20. Dhooge W., Hond E.D., Koppen G., Bruckers L., Nelen V., et al. Internal exposure to pollutants and sex hormone levels in Flemish male adolescents in a cross-sectional study: associations and dose-response relationships. J. Expo. Sci. Environ. Epidemiol. 2011, 21:106-113. 10.1038/jes.2009.63.
21. Dodson R.E., Nishioka M., Standley L.J., Perovich L.J., Brody J.G., Rudel R.A. Endocrine disruptors and asthma-associated chemicals in consumer products. Environ. Health Perspect. 2012, 120(7):935-943.
22. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., et al. Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr. Rev. 2009, 30(4):293-342. 10.1210/er.2009-0002.
23. Endocrine Disruptors From Green Facts: Facts on Health and the Environment 2001, http://www.greenfacts.org/en/endocrine-disruptors/l-2/endocrine-disruptors-4.htm#1 (retrieved 10.08.14).
24. Fechner P., Damdimopoulou P., Gauglitz G. Biosensors paving the way to understanding the interaction between cadmium and the estrogen receptor alpha. PLoS ONE 2011, 6(8):e23048. 10.1371/journal.pone.0023048.
25. Feige J.N., Gelman L., Michalik L., Desvergne B., Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog. Lipid Res. 2006, 45(2):120-159.
26. Gore A.C. Developmental programming and endocrine disruptor effects on reproductive neuroendocrine systems. Front. Neuroendocrinol. 2008, 29(3):358-374. 10.1016/j.yfrne.2008.02.002.
27. Gore A.C. Neuroendocrine targets of endocrine disruptors. Hormones (Athens) 2010, 9(1):16-27.
28. Gore A.C., et al. Introduction to Endocrine Disrupting Chemicals (EDCs) - A Guide for Public Interest Organizations and Policy-makers 2014, Endocrine Society, Available at: http://www.endocrine.org/~/media/endosociety/Files/Advocacy%20and%20Outreach/Important%20Documents/Introduction%20to%20Endocrine%20Disrupting%20Chemicals.pdf.
29. Gibs J., Stackelberg P.E., Furlong E.T., Meyer M., Zaugg S.D., Lippincott R.L. Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time. Sci. Total Environ. 2007, 373(1):240-249.
30. Grun F. Obesogens. Cur. Opin. Endocr. Diabetes Obes. 2010, 17(5):453-459. 10.1097/MED/0b013e32833ddea0.
31. Guengerich F.P., Crawford W.M., Domoradzki J.Y., et al. In vitro activation of 1,2-dichloroethane by microsomal and cytosolic enzyme. Toxicol. Appl. Pharmacol. 1980, 55:303-317.
32. Halling-Sorensen B., Nielsen S.N., Lanzky P.F., Ingerslev F., Holten Lutzhoft H.C., Jorgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36(2):357-393.
33. Hutcheon J., Duncan E., Hutcheon D.E., Kantrowitz J., Russell N., Van Gelder R.N.V., Flynn E., et al. Factors affecting plasma benzo [a] pyrene levels in environmental studies. Environ. Res. 1983, 32(1):104-110. 10.1016/0013-9351(83)90196-2.
34. Irigaray P., Ogier V., Jacquenet S., Notet V., et al. Benzo[a]pyrene impairs β-adrenergic stimulation of adipose tissue lipolysis and causes weight gain in mice: a novel molecular mechanism of toxicity for a common food pollutant. FEBS J. 2006, 273(7):1362-1372. 10.1111/j.1742-4658.2006.05159.x.
35. Kandarakis E.D., Bourguignon J.P., Guidice L.C., et al. Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr. Rev. 2009, 30(4):293-342. 10.1210/er.2009-0002.
36. Kavlock R.J., Daston G.P., DeRosa C., Fenner-Crisp P., Gray L.E., Kaattari S., et al. Research needs for the assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ. Health Perspect. 1996, 104(4):715-740.
37. Kidd K.A., Becher G., Bergman A., Muir D.C.G., Woodruff T.J. Human and wildlife exposures to EDC's. Chapter 3. State of the science of endocrine disrupting chemicals. UNEP 2012, 189-250. Retrieved from: http://www.unep.org/hazardoussubstances/Portals/9/EDC/SOS%202012/EDC%20report%20Ch3.pdf.
38. Kim S.D., Cho J., Kim I.S., Vanderford B.J., Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res. 2007, 41(5):1013-1021.
39. Kim S.S., Kwack S.J., Lee R.D., Lim K.J., Rhee G.S., et al. Assessment of estrogenic and androgenic activities of tetramethrin in vitro and in vivo assays. J. Toxicol. Environ. Health A 2005, 68(23-24):2277-2289. 10.1080/15287390500182453.
40. Kjaerstad M.B., Taxviq C., Andersen H.R., Nellemann C.L. Mixture effects of endocrine disrupting compounds in vitro. Int. J. Androl. 2010, 33(2):425-433.
41. Lelli S.M., Ceballos N.R., Mazzetti M.B., Aldonatti C.A., San Martín de Viale L.C. Hexachlorobenzene as hormonal disruptor - studies about glucocorticoids: their hepatic receptors, adrenal synthesis and plasma levels in relation to impaired gluconeogenesis. Biochem. Pharmacol. 2007, 73(6):873-879.
42. Marty M.S., Carney E.W., Rowlands J.C. Endocrine disruption: historical perspectives and its impact on the future of toxicology testing. Toxicol. Sci. 2011, 120(S1):S93-S108. 10.1093/toxsci/kfq329.
43. Matthiessen P. Historical perspective on endocrine disruption in wildlife. Pure Appl. Chem. 2003, 75(11-12):2197-2206.
44. Mellanen P., Petanen T., Lehtimaki J., Makela S., Bylund G., Holmbom B., et al. Wood-derived estrogens: studies in vitro with breast cancer cell lines and in vivo in trout. Toxicol. Appl. Pharmacol. 1996, 136(2):381-388.
45. Nicolas J.C., Cecile C., Perinnaaz R.W., Marie T., Roselyne G., Jerome M., Carlos S., Jean-Pierre C., Beverly S.R., Ana M.S., Daniel Z. Effects of low doses of bisphenol a on the metabolome of perinatally exposed CD-1 mice. Environ. Health Perspect. 2013, 121(May (5)):586-593.
46. Nicolopoulou-Stamati P., Pitsos M.A. The impact of endocrine disrupters on the female reproductive system. Oxford J. Hum. Reprod. Update 2001, 7(3):323-330. 10.1093/humupd/7.3.323.
47. Patrick Lyn. Thyroid disruption: mechanism and clinical implications in human health. Altern. Med. Rev. 2009, 14(4):326-346.
48. Polyzos S.A., Kountouras J., Deretzi G., Zavos C., Mantzoros C.S. The emerging role of endocrine disruptors in pathogenesis of insulin resistant: a concept implicating nonalcoholic fatty liver disease. Curr. Mol. Med. 2012, 12(1):68-82.
49. Puga A., Ma C., Marlowe J.L. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem. Pharmacol. 2009, 77(4):713-722.
50. Robert J.K., George P.D., Chris D., Penny F.C., Earl Gray L., Steve K., George L., Micheal L., Micheal J.M., Carol M., Ron M., Jack M., Rosalind R., Geoffrey S., Daniel M.S., Thomas S., Hugh A.T. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ. Health Perspect. 1996, 104(4):715-740.
51. Rosenfeldt E.J., Linden K.G. Degradation of endocrine disrupting chemicals bisphenol A, ethinyl estradiol, and estradiol during UV photolysis and advanced oxidation processes. Environ. Sci. Technol. 2004, 38(20):5476-5483. 10.1021/es035413p.
52. Safe S., Astroff B., Harris M., Zacharewski T., Dickerson R., Romkes M., Biegel L. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antioestrogens: characterization and mechanism of action. Pharmacol. Toxicol. 2009, 69(6):400-409.
53. Sam D.C., Nicolas V.L. Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J. Environ. Public Health 2012, 2012.
54. Santodonato J. Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: relationship to carcinogenicity. Chemosphere 1997, 34(4):835-848.
55. Schenck K., Rosenblum L., Wiese T.E., Wymer L., Dugan N., Williams D., et al. Removal of estrogens and estrogenicity through drinking water treatment. J. Water Health 2012, 10(1):43-55. 10.2166/wh.2011.135.
56. Shudong S., Jingyun H., Changsheng Z. Polymeric particles for the removal of endocrine disruptors. Sep. Purif. Rev. 2011, 40:312-337.
57. Somm E., Schwitzgebel V.M., Toulotte A., Cederroth C.R., et al. Perinatal exposure to bisphenol A alters early adipogenesis in the rat. Environ. Health Perspect. 2009, 117(10):1549-1555. 10.1289/ehp.11342.
58. Stumm-Zollinger E., Fair G.M. Biodegradation of steroid hormones. J. Water Pollut. Control Fed. 1965, 37(11):1506-1510. http://www.jstor.org/stable/25035413.
59. Veerasingam S.A., Ali M.M. Assessment of endocrine disruptors - DDTs and DEHP (plasticizer) in source water: a case study from Selangor, Malaysia. J. Water Health 2013, 11(2):311-323.
60. Westerhoff P., Yoon Y., Snyder S., Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 2005, 39(17):6649-6663.
61. UNEP and WHO United Nations Environment Programme and the World Health Organization, 2013. State of the Science of Endocrine Disrupting Chemicals-2012 2013, Available at: http://www.who.int/ceh/publications/endocrine/en/.